IDEAYA Biosciences, Inc. (IDYA)
Form 4 sales, Form 144 notices and lockup dates
- Latest sale
- $382k
- Jul 7 · Routine
- Form 4 sales
- 46
- On record
- Form 144 notices
- 20
- Proposed sales
- Next unlock
- None
- No lockup ahead
Lockups
No lockup on record.
Sales by reason
Timeline
- 1 Form 4 saleRoutineFeb 9, 2024 2024
Sold 2,000 shares at $46.02 ($92k)
Ruiz Briseno Andres, Officer
10b5-1 planSold 7.5% of holdings ($1.2M position)24,531 shares left1x usual sizeFollows a Form 144Filing
- 2 Form 144 noticeNoticeMay 14, 2024 +95 days
Filed to sell 175,000 shares ($7.2M)
Hata Yujiro S, CEO
10b5-1 plan2.3x usual sizeFiling
- 3 Form 4 saleRoutineMay 16, 2024 +2 days
Sold 175,000 shares at $42.27 ($7.4M)
Hata Yujiro S, President and CEO
10b5-1 planSold 20.5% of holdings ($36.1M position)677,887 shares left2.3x usual sizeFollows a Form 144Filing
- 4 Form 144 noticeNoticeMay 29, 2024 +13 days
Filed to sell 28,500 shares ($1.1M)
White Michael Anthony, Officer
10b5-1 planFirst sale on recordFiling
- 5 Form 4 saleRoutineMay 29, 2024 same day
Sold 28,500 shares at $36.25 ($1M)
White Michael Anthony, Chief Scientific Officer
10b5-1 planSold 100% of holdings ($1M position)0 shares leftFirst sale on recordFollows a Form 144Filing
- 6 Form 144 noticeNoticeAug 26, 2024 +89 days
Filed to sell 75,000 shares ($3M)
Throne Jason, Former Officer
No 10b5-1 plan16.7x usual sizeFiling
- 7 Form 144 noticeNoticeJul 7, 2026 +680 days
Filed to sell 9,550 shares ($382k)
Ruiz Briseno Andres, Senior VP
10b5-1 planFirst sale on recordFiling
- 8 Form 4 saleRoutineJul 7, 2026 same day
Sold 9,550 shares at $40.01 ($382k)
Ruiz Briseno Andres, Chief Accounting Officer
10b5-1 planSold 26.5% of holdings ($1.4M position)26,466 shares leftFirst sale on recordFollows a Form 144Filing
Every transaction
Loading transactions…
Sales, notices and lockups (66)
Export watchlist as CSV| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jul 7, 2026 | Jul 9, 2026 | Ruiz Briseno Andres | Chief Accounting Officer | Form 4 sale | 9,550 | $382k | 26.5% | Routine | SEC |
| Jul 7, 2026 | Jul 7, 2026 | Ruiz Briseno Andres | Senior VP | Form 144 notice | 9,550 | $382k | Notice | SEC | |
| Aug 26, 2024 | Aug 26, 2024 | Throne Jason | Former Officer | Form 144 notice | 75,000 | $3M | Notice | SEC | |
| May 29, 2024 | May 31, 2024 | White Michael Anthony | Chief Scientific Officer | Form 4 sale | 28,500 | $1M | 100.0% | Routine | SEC |
| May 29, 2024 | May 29, 2024 | White Michael Anthony | Officer | Form 144 notice | 28,500 | $1.1M | Notice | SEC | |
| May 16, 2024 | May 16, 2024 | Hata Yujiro S | President and CEO | Form 4 sale | 175,000 | $7.4M | 20.5% | Routine | SEC |
| May 14, 2024 | May 14, 2024 | Hata Yujiro S | CEO | Form 144 notice | 175,000 | $7.2M | Notice | SEC | |
| Feb 9, 2024 | Feb 13, 2024 | Ruiz Briseno Andres | Officer | Form 4 sale | 2,000 | $92k | 7.5% | Routine | SEC |
| Feb 9, 2024 | Feb 12, 2024 | Hata Yujiro S | President and CEO | Form 4 sale | 99,372 | $4.5M | 12.8% | Routine | SEC |
| Feb 9, 2024 | Feb 9, 2024 | Ruiz Briseno Andres | Senior VP | Form 144 notice | 14,867 | $678k | Notice | SEC | |
| Feb 1, 2024 | Feb 5, 2024 | Hata Yujiro S | President and CEO | Form 4 sale | 628 | $28k | 0.1% | Routine | SEC |
| Feb 1, 2024 | Feb 1, 2024 | Hata Yujiro S | CEO | Form 144 notice | 100,000 | $4.5M | Notice | SEC | |
| Jan 22, 2024 | Jan 24, 2024 | Ruiz Briseno Andres | Officer | Form 4 sale | 2,000 | $84k | 7.0% | Routine | SEC |
| Jan 16, 2024 | Jan 17, 2024 | Hata Yujiro S | President and CEO | Form 4 sale | 75,000 | $3M | 10.0% | Routine | SEC |
| Jan 12, 2024 | Jan 17, 2024 | Ruiz Briseno Andres | Officer | Form 4 sale | 2,000 | $76k | 6.6% | Routine | SEC |
| Jan 12, 2024 | Jan 12, 2024 | Ruiz Briseno Andres | Senior VP | Form 144 notice | 4,000 | $149k | Notice | SEC | |
| Jan 12, 2024 | Jan 12, 2024 | Hata Yujiro S | CEO | Form 144 notice | 75,000 | $3M | Notice | SEC | |
| Dec 27, 2023 | Dec 27, 2023 | Stone Paul A. | Officer | Form 144 notice | 55,680 | $2M | Notice | SEC | |
| Dec 15, 2023 | Dec 19, 2023 | Throne Jason | Chief Legal Officer | Form 4 sale | 10,000 | $350k | 100.0% | Routine | SEC |
| Dec 15, 2023 | Dec 19, 2023 | Hata Yujiro S | President and CEO | Form 4 sale | 75,000 | $2.6M | 10.0% | Routine | SEC |
| Dec 15, 2023 | Dec 15, 2023 | Hata Yujiro S | CEO | Form 144 notice | 75,000 | $2.6M | Notice | SEC | |
| Dec 15, 2023 | Dec 15, 2023 | Throne Jason | Officer | Form 144 notice | 10,000 | $350k | Notice | SEC | |
| Dec 14, 2023 | Dec 18, 2023 | Ruiz Briseno Andres | Officer | Form 4 sale | 2,000 | $68k | 6.1% | Routine | SEC |
| Dec 14, 2023 | Dec 14, 2023 | Ruiz Briseno Andres | Senior VP | Form 144 notice | 2,000 | $68k | Notice | SEC | |
| Dec 11, 2023 | Dec 11, 2023 | Stone Paul A. | Officer | Form 144 notice | 44,875 | $1.4M | Notice | SEC | |
| Dec 4, 2023 | Dec 4, 2023 | Stone Paul A. | Officer | Form 144 notice | 42,964 | $1.4M | Notice | SEC | |
| Nov 28, 2023 | Nov 28, 2023 | Stone Paul A. | Officer | Form 144 notice | 39,450 | $1.2M | Notice | SEC | |
| Nov 27, 2023 | Nov 27, 2023 | Stone Paul A. | Officer | Form 144 notice | 46,654 | $1.5M | Notice | SEC | |
| Nov 3, 2023 | Nov 7, 2023 | Throne Jason | Chief Legal Officer | Form 4 sale | 5,163 | $155k | 100.0% | Routine | SEC |
| Sep 12, 2023 | Sep 14, 2023 | Throne Jason | Chief Legal Officer | Form 4 sale | 1,000 | $30k | 100.0% | Routine | SEC |
| Sep 5, 2023 | Sep 6, 2023 | Throne Jason | Chief Legal Officer | Form 4 sale | 3,837 | $115k | 100.0% | Routine | SEC |
| Sep 1, 2023 | Sep 6, 2023 | Ruiz Briseno Andres | Officer | Form 4 sale | 2,000 | $60k | 5.8% | Routine | SEC |
| Sep 1, 2023 | Sep 1, 2023 | Throne Jason | Officer | Form 144 notice | 20,000 | $600k | Notice | SEC | |
| Aug 29, 2023 | Aug 31, 2023 | Stone Paul A. | Chief Financial Officer | Form 4 sale | 5,000 | $144k | 35.0% | Routine | SEC |
| Aug 21, 2023 | Aug 23, 2023 | Stone Paul A. | Chief Financial Officer | Form 4 sale | 978 | $26k | 6.4% | Routine | SEC |
| Aug 18, 2023 | Aug 18, 2023 | Stone Paul A. | Chief Financial Officer | Form 4 sale | 4,022 | $106k | 20.8% | Routine | SEC |
| Aug 9, 2023 | Aug 11, 2023 | Throne Jason | Chief Legal Officer | Form 4 sale | 5,000 | $125k | 100.0% | Routine | SEC |
| Aug 9, 2023 | Aug 11, 2023 | Stone Paul A. | Chief Financial Officer | Form 4 sale | 2,500 | $63k | 11.5% | Routine | SEC |
| Aug 9, 2023 | Aug 9, 2023 | Stone Paul A. | Officer | Form 144 notice | 12,500 | $313k | Notice | SEC | |
| Jul 10, 2023 | Jul 12, 2023 | Throne Jason | Chief Legal Officer | Form 4 sale | 9,485 | $218k | 100.0% | Routine | SEC |
| Jul 10, 2023 | Jul 10, 2023 | Throne Jason | Officer | Form 144 notice | 14,485 | $330k | Notice | SEC | |
| Jun 1, 2023 | Jun 2, 2023 | Throne Jason | Chief Legal Officer | Form 4 sale | 3,985 | $92k | 100.0% | Routine | SEC |
| May 22, 2023 | May 24, 2023 | Throne Jason | Chief Legal Officer | Form 4 sale | 500 | $12k | 100.0% | Routine | SEC |
| May 22, 2023 | May 22, 2023 | Throne Jason | affiliate | Form 144 notice | 4,485 | $96k | Notice | SEC | |
| Oct 4, 2021 | Oct 7, 2021 | Dillon Michael P. | SVP, Chief Scientific Officer | Form 4 sale | 1,500 | $40k | 1.9% | Plan not stated | SEC |
| Sep 8, 2021 | Sep 9, 2021 | Dillon Michael P. | SVP, Chief Scientific Officer | Form 4 sale | 11,500 | $315k | 12.7% | Plan not stated | SEC |
| Sep 7, 2021 | Sep 9, 2021 | Stone Paul A. | SVP, Chief Financial Officer | Form 4 sale | 2,500 | $69k | 16.2% | Plan not stated | SEC |
| Sep 2, 2021 | Sep 7, 2021 | Dillon Michael P. | SVP, Chief Scientific Officer | Form 4 sale | 10,000 | $251k | 11.3% | Plan not stated | SEC |
| Aug 9, 2021 | Aug 11, 2021 | Dillon Michael P. | SVP, Chief Scientific Officer | Form 4 sale | 11,500 | $264k | 11.5% | Plan not stated | SEC |
| Jul 27, 2021 | Jul 29, 2021 | Dillon Michael P. | SVP, Chief Scientific Officer | Form 4 sale | 10,000 | $252k | 9.2% | Plan not stated | SEC |
| Jul 27, 2021 | Jul 29, 2021 | Throne Jason | SVP, General Counsel | Form 4 sale | 10,000 | $252k | 100.0% | Unusual | SEC |
| Jul 6, 2021 | Jul 8, 2021 | Dillon Michael P. | SVP, Chief Scientific Officer | Form 4 sale | 1,500 | $33k | 1.5% | Plan not stated | SEC |
| Jul 6, 2021 | Jul 8, 2021 | Throne Jason | SVP, General Counsel | Form 4 sale | 10,000 | $222k | 100.0% | Unusual | SEC |
| Jun 17, 2021 | Jun 17, 2021 | Dillon Michael P. | SVP, Chief Scientific Officer | Form 4 sale | 5,000 | $112k | 4.8% | Plan not stated | SEC |
| Jun 7, 2021 | Jun 9, 2021 | Dillon Michael P. | SVP, Chief Scientific Officer | Form 4 sale | 1,500 | $30k | 1.5% | Plan not stated | SEC |
| May 11, 2021 | May 13, 2021 | Dillon Michael P. | SVP, Chief Scientific Officer | Form 4 sale | 5,000 | $101k | 4.8% | Plan not stated | SEC |
| Feb 10, 2021 | Feb 10, 2021 | Lackner Mark | SVP, Head of Biology | Form 4 sale | 2,000 | $42k | 100.0% | Unusual | SEC |
| Feb 9, 2021 | Feb 10, 2021 | Dillon Michael P. | SVP, Chief Scientific Officer | Form 4 sale | 5,000 | $104k | 4.8% | Plan not stated | SEC |
| Feb 2, 2021 | Feb 4, 2021 | Bvf Partners L P/il | Other | Form 4 sale | 46,409 | $835k | 16.6% | Plan not stated | SEC |
| Jan 26, 2021 | Jan 28, 2021 | Lackner Mark | SVP, Head of Biology | Form 4 sale | 2,501 | $46k | 100.0% | Unusual | SEC |
| Dec 4, 2020 | Dec 8, 2020 | Throne Jason | SVP, General Counsel | Form 4 sale | 1,979 | $30k | 100.0% | Unusual | SEC |
| Nov 11, 2020 | Nov 13, 2020 | Schwab Andrew J. | 10% owner | Form 4 sale | 800,000 | $10.9M | 67.5% | Unusual | SEC |
| Jun 17, 2020 | Jun 19, 2020 | Stone Paul A. | Chief Financial Officer | Form 4 sale | 3,100 | $56k | 17.1% | Plan not stated | SEC |
| Jun 17, 2020 | Jun 18, 2020 | Lackner Mark | SVP, Head of Biology | Form 4 sale | 7,123 | $108k | 100.0% | Unusual | SEC |
| Jun 4, 2020 | Jun 8, 2020 | Throne Jason | VP, General Counsel | Form 4 sale | 2,205 | $19k | 100.0% | Unusual | SEC |
| Jun 2, 2020 | Jun 4, 2020 | Lackner Mark | SVP, Head of Biology | Form 4 sale | 845 | $8k | 100.0% | Unusual | SEC |